English
Back
Download
Log in to access Online Inquiry
Back to the Top

NEWS

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

Monday, 2nd December at 7:50 am
The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell's pivotal Phase 3 study of Bria-IMT™ plus an immune check point inhibitor in metastatic breast cancer
The pivotal Phase 3 study is currently under Fast Track Designation with the Food and Drug Administration (FDA)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
7462 Views
Comment
Sign in to post a comment
    Spread kindness and love. Life is short. Don’t let greed eat you.
    8803
    Followers
    53
    Following
    103K
    Visitors
    Follow